Legacy Wealth Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,437	Closed	-$931K	–	342
2024 Q1	$931K	Buy	3,437 +24	+0.7%	+$5.73K	0.26%	109
2023 Q4	$807K	Buy	3,413 +19	+0.6%	+$3.74K	0.26%	109
2023 Q3	$665K	Buy	3,394 +36	+1%	+$7.39K	0.24%	128
2023 Q2	$706K	Buy	3,358 +209	+7%	+$41.6K	0.25%	126
2023 Q1	$636K	Buy	3,149 +591	+23%	+$134K	0.23%	147
2022 Q4	$557K	Buy	2,558 +342	+15%	+$74.7K	0.21%	161
2022 Q3	$436K	Buy	2,216 +999	+82%	+$216K	0.19%	184
2022 Q2	$260K	Buy	1,217 +81	+7%	+$19.8K	0.11%	251
2022 Q1	$323K	Buy	1,136 +40	+4%	+$12.3K	0.12%	242
2021 Q4	$413K	Sell	1,096 -90	-8%	-$35K	0.14%	221
2021 Q3	$489K	Sell	1,186 -26	-2%	-$10.8K	0.22%	174
2021 Q2	$448K	Sell	1,212 -189	-13%	-$63.1K	0.2%	188
2021 Q1	$406K	Sell	1,401 -7	-0.5%	-$1.95K	0.19%	202
2020 Q4	$352K	Buy	+1,408	New	+$335K	0.18%	212